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Abstract 
 
The value and challenges of establishing and maintaining a successful doctor-
patient relationship are thrown into sharp relief in the treatment of people with 
Borderline Personality Disorder. In this paper, we present an overview of this 
common and important condition, its epidemiology, aetiology, common 
comorbidities and neurological associations. We then propose a practical, 
psychologically-informed framework for enhancing the therapeutic alliance in the 
management of these patients for the jobbing neurologist. 
 
 
Introduction 
 
Neurologists encounter people with personality disorder in their outpatient clinics, 
the emergency department and on the medical wards. People with Borderline 
Personality Disorder (BPD) characteristically experience distressing disturbances 
in self-image, impulsivity, problems with emotional regulation and pervasive 
difficulties in interpersonal relationships. They are at increased risk of self-harm 
and suicide, and experience higher rates of somatisation. Reasons for neurology 
referrals in this patient group include dissociative seizures, conversion disorders 
and other functional neurological impairments, of course in addition to standard 
neurological presentations, including those occurring in the context of head injury, 
as well as alcohol and substance misuse. 
 
In such contexts, successful management of the prima facie problem is likely to 
involve a deeper consideration of a person’s life experiences and subsequent 
relational difficulties; these may be contributing to their neurological presentation 
and will certainly impact upon the doctor-patient relationship. Although it is not 
within the remit of a neurologist to treat underlying personality disorder,  
an astute approach to the therapeutic alliance will enhance treatment outcomes in 
these patients. In order to achieve this, the neurologist will benefit from an 
understanding of this common condition, and of associated pitfalls frequently 
encountered by health professionals in the approach to management. 
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Definition 
 
‘The borderland’ 
 
The term ‘borderline personality’, now a source of confusion, was first used in 1938 
by Adolph Stern to describe a group of patients who ‘fit frankly neither into the 
psychotic nor into the psychoneurotic group’, but inhabited a realm between the 
two (1). 
 
The definition and classification of BPD have been heavily debated, reflecting 
persisting uncertainty in how best to conceptualise the underlying 
psychopathology. Personality disorder (PD) is defined in the International 
Classification of Diseases (ICD)-11 as: 
 
‘a relatively enduring and pervasive disturbance in how individuals 
experience and interpret themselves, others, and the world that results in 
maladaptive patterns of cognition, emotional experience, emotional 
expression, and behaviour’ (2). 
 
These maladaptive patterns commonly have their first manifestations in childhood 
and adolescence, and are typically associated with instability in interpersonal 
relationships. In ICD-10, ‘borderline type’ PD comes under the umbrella term of 
‘Emotionally Unstable Personality Disorder’ (EUPD), alongside ‘impulsive type’ PD. 
As there is considerable overlap between the categories, the term EUPD is 
sometimes used interchangeably with BPD in the clinical setting. The move away 
from categorical descriptions of personality disorder towards dimensional 
classification in ICD-11 signifies a major nosological overhaul (3). The DSM-5 
criteria for BPD are displayed in Box 1; five or more of these criteria are required 
for a diagnosis of BPD to be made (4). 
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Box 1: Features of BPD 
 
Adapted from the ICD-11 Clinical Descriptions and Diagnostic Guidelines for Personality 
Disorder (5), based on the American Psychiatric Association’s Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-5 (4). 
 
What’s in a name? 
 
It is noteworthy that the term ‘personality disorder’ is all-too-often used in a 
pejorative sense, with authors of a 2015 Lancet series on the subject going so far 
as to lament that ‘it has now become more a term of abuse than a diagnosis’ (2). It 
is important for all doctors to maintain an open mind and compassionate approach 
when dealing with patients diagnosed with personality disorder. This requires skill 
and patience as the psychopathology of these patients usually chiefly manifests 
itself in the manner in which they interact with others.  
 
 
Epidemiology 
 
In the Western world, where the majority of the research in this area has been 
conducted, BPD has been found to have a lifetime prevalence of around 6% (6) 
and a community prevalence of approximately 1-3% (6, 7). Sociodemographic 
• Frantic efforts to avoid real or imagined abandonment. 
• A pattern of unstable and intense interpersonal relationships, typically 
characterised by alternating between extremes of idealisation and 
devaluation. 
• Identity disturbance, manifested in markedly and persistently unstable self-
image or sense of self. 
• Impulsivity manifested in potentially self-damaging behaviours (e.g., risky 
sexual behaviour, reckless driving, excessive alcohol or substance use, binge 
eating). 
• Recurrent episodes of self-harm including suicide attempts. 
• Emotional instability due to marked reactivity of mood. Fluctuations of mood 
may be triggered either internally (by one’s own thoughts) or by external 
events. As a consequence, the individual experiences intense dysphoric 
mood states, which typically last for a few hours but may last for up to several 
days. 
• Chronic feelings of emptiness. 
• Difficulty controlling anger. 
• Transient dissociative symptoms or psychotic-like features such as transient 
hallucinations and paranoia, typically in situations of high affective arousal. 
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correlates include younger age, living in urban centres and not living with a partner 
(8), as well as low socioeconomic status (9). 
 
Although women with BPD are disproportionately represented in clinical settings 
compared to men, community samples do not identify a clear difference in 
prevalence of BPD between women and men (1, 8, 10). 
 
BPD affects 4-6% of those attending primary care services (11, 12), and, 
compared to those without BPD, individuals with BPD attend their GP more 
frequently and report greater psychosocial impairment (13). As many as 40% of 
those in contact with secondary mental health services are affected by personality 
disorder, of which BPD is the most common type (14). 
 
 
Aetiology 
 
In common with other psychiatric disorders, the aetiology of BPD is multifactorial.  
Various interdisciplinary attempts have been made to integrate the complex array 
of underlying aetiological factors, yet there remains much to be discovered. One 
such influential model is Linehan’s biosocial model which proposes BPD as arising 
from an emotionally vulnerable temperament (biological vulnerabilities) interacting 
with an invalidating environment (psychosocial factors) (15).  
 
Recognised contributors to the aetiology of BPD include genetic vulnerabilities and 
a multitude of environmental factors, particularly adverse childhood experiences 
(8). 
 
Genetics 
 
Twin studies have demonstrated moderate to high heritability for BPD (16). No 
robust evidence has yet been established for single-candidate genes, and genome 
wide association studies in this area are in their relative infancy (17, 18). Several 
small gene-environment studies have identified interactions which need verifying in 
larger, prospective cohorts (18). 
 
Epigenetic studies examine how environmental conditions affect gene expression, 
and are increasingly being considered a promising avenue for exploring the 
aetiology of PDs (19). Several small studies suggest epigenetic 
modifications in people with BPD in genes related to stress and neurodevelopment, 
with environmental factors such as childhood trauma having a measurable impact 
on genes responsible for neurofunctioning (18, 19)
. For 
example, people with BPD have been shown to have significantly higher DNA 
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methylation, i.e. evidence of epigenetic modification, of the brain-derived 
neurotrophic factor (BDNF) gene, which is involved in neurodevelopment (20). 
Such epigenetic changes may pave the way for new treatment approaches, but 
further research is needed to establish this (20). 
 
Psychosocial factors 
 
Early environmental and familial risk factors for BPD have been consistently 
demonstrated over the years. These include childhood trauma such as neglect and 
abuse (emotional, physical or sexual), familial adversity, a history of 
psychopathology in the caregiver, as well as parental emotional under-involvement 
(1, 9). 
 
The marked association between childhood sexual abuse and the development of 
BPD, and the positive correlation between the severity of BPD and the severity of 
the abuse experienced, have led some researchers to argue that people with BPD 
might be better thought of as having a chronic form post-traumatic stress disorder 
(PTSD) (21). Clearly not all people who experience abuse go on to develop BPD, 
and the fact that abuse alone is neither necessary nor sufficient for its development 
points to other predisposing (such as genetic) and contextual mediating factors (1). 
For example, emotional denial of a child’s experience of trauma by their caregiver 
has been identified as a predictor for BPD (22). The family and wider social 
environment are considered to play a critical role, as well as whether a child’s 
perspective on their emotional world is perceived to be validated (1). 
 
A note on attachment 
 
Attachment theory, developed by John Bowlby, posits the universal human need 
for close affectional bonds as a prerequisite for normal development.  
When a child has a mental representation of the caregiver as available and 
responsive to their needs, secure attachment occurs. BPD is strongly associated 
with insecure attachment (1), which occurs when self-perceptions of internal states 
are instead undermined. It is not clear to what extent attachment difficulties in BPD 
are causal to or result from the emotional disturbance and impulsivity associated 
with the condition. 
 
Neurobiology 
 
A number of neural correlates associated with BPD have been reported. 
Structurally, reduced amygdala and hippocampal volumes have been observed (1). 
Functionally, evidence exists for increased limbic activity and decreased prefrontal 
activity in patients with BPD in response to emotional stimuli, in keeping with 
clinical observations of emotional dysregulation (23). 
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People with BPD have also been consistently shown to experience a negative 
response bias to ambiguous or neutral facial expressions, as well as an enhanced 
sensitivity to fearful expressions (24). Contrary to popular misconception, people 
with BPD have demonstrable accuracy in determining mental states in response to 
complex social stimuli (24), and these patients are exquisitely sensitive to the 
states of mind of those around them. 
 
On examination, patients with BPD have been found to exhibit higher rates of 
neurological soft signs in keeping with underlying non-focal neurological 
dysfunction (25). 
 
 
Comorbidities 
 
Psychiatric comorbidities 
 
Depression, anxiety and substance misuse disorders, as well as eating disorders, 
PTSD and bipolar disorder, are all important diagnostic comorbidities (1, 16). 
 
It can be challenging for the clinician to distinguish comorbidity in patients with 
BPD; for example, the emotional dysregulation seen in people with BPD may 
mimic depression, mania or anxiety. In this respect, it is invariably helpful to obtain 
an informant account in order to establish the duration and onset of symptoms. 
 
Many people with BPD engage in repeated episodes of self-harm and . These 
impulsive and apparently self-destructive behaviours signify different meanings for 
different people, and may range from seeking relief or distraction from acute 
distress, to attempting to reconnect with one’s emotions in the face of dissociation 
or feelings of emptiness (1). Many patients endure recurrent thoughts of suicide 
and suicide attempts; the mortality rate for people with BPD from suicide has been 
estimated to be as high as 8-10%, 50-times higher than that in the general 
population (16). 
 
Physical comorbidities 
 
People with personality disorders have an average life expectancy starkly reduced 
by around two decades compared to the general population (26, 27). The excess 
mortality cannot be attributed to increased suicide rates alone and it is now 
apparent that people with BPD experience significantly poorer physical health 
compared with individuals not diagnosed with BPD. Rates of cardiovascular and 
cerebrovascular disease are substantially increased (25), and associations have 
also been reported between BPD and gastrointestinal and hepatic diseases, 
arthritis, sleep disorders and chronic pain, as well as syncope and seizures (28). 
Commented [MOU1]: This has now been moved to the risk 
management section. 
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The underlying mechanisms for this disproportionate burden of illness are 
unknown; lifestyle factors such as higher rates of smoking and poorer diet are likely 
to be implicated, as well as the toll taken by chronic levels of psychological stress 
on the body (28). 
 
People with BPD may also present to neurologists given their increased rates of 
migraine-related disability and a lower likelihood of responding to pharmacological 
headache treatment compared to controls (29), or due to neurological sequelae of 
self-injury and substance use disorders. 
 
Functional neurological associations 
 
Across the boundary between psychiatric and physical comorbidities of BPD lie the 
somatoform disorders, renamed ‘somatic symptom disorder’ in DSM-5 and ‘bodily 
distress disorder’ in ICD-11 (30). 
 
Under this category is ‘conversion’ (functional neurological symptom) disorder, 
which refers to patients with neurological symptoms such as seizures, limb 
weakness and movement disorders without identifiable organic disease (31). 
Conversion disorder is one of the most common reasons for referral to neurology 
(31), and co-occurring BPD has been found to affect a significant proportion of 
people with conversion disorder (22%) (32). 
 
Not only has substantial comorbidity been demonstrated between BPD and 
somatic symptom disorders, but these conditions also share two important 
commonalities: an association with a history of childhood trauma and features of 
emotional dysregulation (32). Such common denominators have also been noted 
between BPD and the specific example of psychogenic non-epileptic seizures 
(PNES), which can fall within both conversion and dissociative disorders (33). 
 
 
Functional neurological symptom disorder 
 
For much of the last century since Breuer and Freud’s hypothesis that 
psychological distress was ‘converted’ into physical symptoms, psychiatric 
formulations of the so-named disorder have dominated. 
 
The nosological shift from ‘conversion’ to ‘functional neurological symptom’ 
disorder in DSM-5 represents an important swing of the pendulum back towards 
neurology, with both fields having valuable perspectives. To neurologists, 
functional neurological symptom disorders are no longer diagnoses to be excluded 
and referred back. Rather, neurologists are increasingly recognised as having an 
important therapeutic role (34). Reflecting this shift, diagnostic criteria now demand 
positive neurological examination features (for example Hoover’s sign of functional 
leg weakness) (35). 
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Diagnostic overshadowing 
 
In closing this section about neurological associations with BPD, we think that it is 
important to remind the reader of this process whereby the cause of physical 
symptoms is misattributed to mental illness, a process termed ‘diagnostic 
overshadowing’. Examples include people with psychiatric disorders and ischaemic 
heart disease being less likely to receive the required revascularisation procedure 
than those without mental illness, and hospital admission for diabetic complications 
being less likely to be offered to those with comorbid psychiatric disorders than 
those without (36). 
 
A range of contributors to this phenomenon have been postulated, including 
clinicians’ biases, naivety about how psychiatric disorders present, and 
complexities of doctor-patient communication (36). 
 
Patients will therefore benefit from neurologists retaining their sharp clinical eye for 
organic neurological diseases regardless of the thickness of the clinical notes, past 
psychiatric history or current affective presentation. 
 
 
Summary of psychiatric management of borderline personality 
disorder 
 
Management options for BPD have considerably advanced over the past twenty 
years. The primary treatment is considered to be psychotherapy, of which several 
methods have been adapted for the disorder. These include dialectical behavioural 
therapy (DBT), cognitive behavioural therapy (CBT), schema-focused therapy 
(SFT) and specific forms of psychodynamic psychotherapy such as mentalisation-
based therapy (MBT) and transference-focused psychotherapy (TFP) (37). There 
is some evidence that these approaches are more effective than treatment as 
usual in certain aspects of BPD such as suicidality (16, 38, 39). Arts therapies and 
family therapy can also play important roles (1). 
 
Pharmacotherapy for BPD is only advised as adjunctive treatment, either for 
comorbidities or for short-term symptomatic relief during crises (1). Guidelines from 
the National Institute for Health and Care Excellence (NICE) are clear that: 
 
‘drug treatment should not be used specifically for borderline personality 
disorder or for the individual symptoms or behaviour associated with the 
disorder (for example, repeated self-harm, marked emotional instability, risk-
taking behaviour and transient psychotic symptoms).’ (40) 
 
During a crisis, short-term pharmacological treatment can be helpful when the 
decision is reached collaboratively with the patient. Where possible, a single drug 
  9 
with low addictive properties and relative safety in overdose is preferred, for 
example a sedative antihistamine. For example, promethazine can be used at a 
dose of 25mg to 50mg, with a maximum dose within 24 hours of 100mg, though its 
use is off-licence. It is recommended by NICE that the minimum effective dose of 
any medication is used, and that a plan should be developed to stop treatment 
started during the crisis, usually within one week (40).  
 
 
Risk management 
 
Many patients with BPD self-harm for example by cutting, scratching or burning. 
Such behaviour can serve many different functions, from dampening down painful 
emotions, to attempting to reconnect with one’s emotions in the face of dissociation 
or feelings of emptiness, or as a way of regulating relationships by either pulling 
people in as rescuers or pushing them away (41).(1) They may also suffer from 
chronic thoughts of suicide. However, it is important to consider obtaining urgent 
advice from a psychiatrist if there has been a recent change in the patient’s self-
harming (for example escalation now requiring medical attention), or when a 
patient states an intensified intent to end their life in relation to their suicidal 
thinking. 
 
Some therapies de-jargonised (37) 
 
Dialectical behaviour therapy 
- Combines certain principles of CBT with mindfulness, Zen-Buddhistic and 
dialectical thinking strategies 
- Aims for behavioural change and enhanced distress tolerance, emotional 
regulation and interpersonal behaviour 
 
Mentalisation-based therapy 
- Draws on psychodynamic and attachment-based principles 
- Aims to improve a person’s ability to apprehend their own feelings and those 
which they evoke in others 
 
Schema-focused therapy 
- Combines CBT with psychoanalysis 
- Aims to identify core maladaptive themes stemming from unmet childhood 
emotional needs, encouraging more adaptive coping styles 
 
Transference-focused psychotherapy 
- Employs clarification, confrontation and interpretation of the therapeutic 
relationship to work towards integrated representations of self and others 
 
 
Can people with BPD recover? 
 
Formatted: Font: Italic
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Prospective longitudinal research has shown that the majority of patients with BPD 
experience a significant remission in symptoms (notably self-harm) over a 10-year 
period. However, functional impairment remains an enduring feature of BPD and 
many people with BPD experience lifelong difficulties in maintaining work and 
intimate relationships (42, 43). 
 
 
Key considerations for the doctor-patient relationship in the 
context of patients with borderline personality disorder 
 
In this section, we outline some ideas and opinions derived through our own 
experience, supplemented by research relevant to neurological practice. 
 
 
1. Recognising its importance 
 
It is well-known that a robust and positive doctor-patient relationship is associated 
with better treatment adherence and outcomes, and that a poor relationship is 
linked to higher dropout rates from treatment (44).  
 
In a previous review for this journal, Stone compellingly outlined how, with a good 
therapeutic alliance, a neurological assessment itself can also be a form of 
treatment for functional disorders. Useful tips included emphasising that the 
symptoms are real and potentially treatable, outlining the positive nature of the 
diagnosis (rather than treating it as a diagnosis of exclusion), simple signposting to 
appropriate help and information possibly including psychological services, and 
offering outpatient follow-up (35). 
 
In the context of psychotherapy, the trust and empathy developed within 
therapeutic relationships is believed to contribute to a corrective relational 
experience in these patients who might otherwise have had very little reason to 
trust in others (15). These principles can also be usefully applied in the 
management of organic neurological disorders in people with comorbid BPD. 
 
 
 
 
2. Collaboration 
 
Whatever the reason for referral, inviting and encouraging the patient’s lived 
experience and understanding of the problem will invariably be a constructive place 
to start (33). In the example of people with BPD and PNES, the building of a 
shared explanatory framework for the cause of seizures is preferable to the 
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imposition of a medically modelled explanation – with higher chances of patients 
both understanding and accepting their diagnosis (33, 45). A collaboratively-built, 
blame-free narrative of the person’s difficulties also forms a foundation on which to 
negotiate realistic treatment goals (30). 
 
In addition, collaboration within the treating clinical team is of particular importance 
for these patients. Because people with personality disorder often have disordered 
attachment styles and difficulties in relationships, powerful dynamics can emerge 
with and within the medical teams. One example is ‘splitting’, a suggested 
unconscious psychological response to stress which leads to experiencing the self 
or others as either entirely ‘good’ or entirely ‘bad’. It is proposed to originate in 
early life, for example through allowing a child to ‘split off’ threatening perceptions 
of a caregiver and thereby maintaining a ‘good’ representation of that caregiver 
(46). This process is thought to translate interpersonally, with patients perceiving 
certain members of staff as ‘good’ whilst others are perceived to be ‘bad’. The net 
result of this is that sometimes staff can be unwittingly drawn into bitter arguments 
about a patient’s behaviour or management Staff can become polarised in this way 
and find themselves bitterly arguing about a patient’s behaviour or treatment (15). 
However, if team members are able to maintain a supportive approach to the 
patient, this may go some way to mitigating this phenomenon. Moreover, as is 
done in DBT, clinicians confronted with denigration of another healthcare 
professional by the patient are encouraged neither to agree with the patient nor to 
defend the other, as shown in Picture 1, to avoid becoming trapped in an unhelpful 
conversation (46). 
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Picture 1: A suggestion on how to notice and avoid being drawn into a 
conversation possibly around ‘splitting’. 
 
A summary of splittingthis and other patterns, along with suggested solutions, is 
provided in Ttable 1. Being alert to these manifestations may help with identifying, 
understanding and assisting patients with personality difficulties (33). 
 
Service-level collaboration is also critical. Poor communication between 
psychiatrists and neurologist colleagues has been attributed to worse outcomes for 
patients with PNES (45). Innovative collaborative approaches have been proposed, 
such as ongoing psychological supervision for neurologists, which could be 
provided, for example, by a psychiatrist consulting for an epilepsy service (33). 
 
 
3. Being mindful of how a patient’s background history can 
impact their current behaviour 
 
 
During difficult consultations, we find it helpful to be cognisant that people act in the 
way that they do for all sorts of complex reasons; people with personality disorder 
may have been repeatedly let down in the past. 
 
This does not mean that the neurologist should be expected to accept abusive or 
attacking behaviour (we will come onto boundary-setting later). However, it can be 
Formatted: Font: Helvetica, Font color: Text 1
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liberating to understand that the anger or resentment manifest in front of us is 
unlikely to be personal but may instead result from a defensive pattern of 
behaviour historically adopted by the patient in the face of extreme adversity. 
 
Such phenomena can be conceptualised by psychological theories such as 
projection - a proposed unconscious defence mechanism whereby, as a way of 
coping with undesirable and painful emotions, these are ‘projected’ onto someone 
else (15). In our experience, understanding of these issues often enables a calm 
hearing and response, which can de-escalate heated conversations and allow for 
more rational discourse. Such outcomes are facilitated by cultivation of one’s own 
emotional awareness as a doctor. 
 
 
4. Knowing oneself – using one’s own feelings as a clinical 
tool 
 
The doctor-patient relationship can essentially be stripped down to an interaction 
between two human beings, each with their own respective set of values and 
vulnerabilities. It is thus logical that if a patient has difficulties with emotional 
regulation, going from one extreme emotion to the next without obvious trigger, the 
encounter may provoke reactions which feel unusually and surprisingly strong in 
the physician. This can be referred to in psychoanalytic terms as a 
countertransference reaction, and, if noticed by the physician, is postulated to 
provide data on the patient’s mental state (15). For example, a neurologist who 
fails to come up with a clear explanation for a patient’s medical symptoms may, 
following an appointment with the patient, end up feeling useless and powerless.  
Rather than reacting defensively, the doctor may wonder whether this feeling of 
uselessness tells him or her something about the patient’s feelings towards 
themselves i.e. that they are possibly connecting with the patient’s own feelings of 
powerlessness. 
 
 
5. Maintaining appropriate boundaries 
 
As part of their problems in interpersonal relationships, patients with BPD 
sometimes have difficulty understanding and observing the boundaries of others. 
The issue may manifest in the form of erratic appointment attendance, excessive 
contact between appointments or inappropriate requests for medication or hospital 
admission (33). Whilst clearly demonstrating our wish to help, it is equally 
important to be clear about the limits of what can be offered. It can be containing 
for the patient if the doctor combines empathy with consistency, transparency and 
clarity about appropriate doctor-patient interaction, expectations and shared 
management goals (15). 
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Clear limit-setting is also encouraged in the context of pharmacological 
management in patients with BPD. Examples relevant to the neurologist might 
include tackling medication overuse for patients with headaches (29), and treading 
the line between collaboration and firmness when reviewing antiepileptic 
medication in patients with PNES (33). 
 
When setting boundaries, it can be helpful to adopt a mentalising approach with 
patients, to allow them to see the rationale for the limit-setting. People with BPD 
have been shown to have difficulties with mentalising, which has been defined by 
Bateman and Fonagy as: 
 
‘the process by which we make sense of each other and ourselves, implicitly 
and explicitly, in terms of subjective mental processes’ (47) 
 
This can be as simple as letting the patient in on one’s thought process, as 
exemplified belowin Picture 2. 
 
 
Picture 2: A suggestion on sharing a dilemma with the patient. 
Neurolgist: “I’m thinking through te dilemma bout he antiepileptic tablets. On the one hand, you’ve told me that hey help you and that you fel you ned something, and Iwant o find a treatment which elps. On the other hand, Iknow from profesional experince that hes tablets can do more harm than god in situations like yours. That’s why Ithink that we should explore together a more apropriate form of treatment o replace the tablets in due course”. 
 
Formatted: Font: (Default) Helvetica
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6. Responsibility and capacity 
 
Some clinicians are quick to characterise behaviours of people with BPD such as 
self-harming as ‘manipulative’ in nature. In our experience, the most productive 
approach is finding a line between encouraging patients to take responsibility over 
their health and healthcare, whilst not blaming them for their situation. A feeling of 
disempowerment can already permeate the lives of many with BPD, so the 
aforementioned boundaries should not be held so strictly as to add to this feeling 
when it comes to treatment decisions. Whenever the opportunity presents itself, 
encouraging a patient’s sense of autonomy, competence and participation in 
healthcare decisions is recommended. However, emotional dysregulation and the 
other psychological difficulties seen in BPD can sometimes cause substantial 
difficulties in using and weighing information (48). Thus, it is sometimes 
appropriate and necessary to use the Mental Capacity Act in order to enforce 
medical treatment in a patient’s ‘best interest’ if there are concerns about their 
mental capacity in relation to treatment refusal for a medical condition (48). 
 
7. Time and consistency 
 
Neurologists may fairly accuse psychiatrists urging them to take more time in 
consultation with people with BPD as misunderstanding the challenges faced in 
their practice. Nevertheless, Stone encourages reflection that neurosurgeons do 
not allocate the same time slots for pituitary tumour removals as for carpal tunnel 
decompressions (35). In a similar vein, longer initial assessments for people with 
BPD and complex functional neurological problems are likely to be worthwhile in 
the long term, as trust is built more easily with less time constraint. 
 
For example, some patients with BPD may find aspects of the neurological 
examination threatening or intrusive, depending in part on previous traumatic 
experiences. Being particularly clear about the process and purpose of the 
examination, though more time-consuming, is likely to help patients to feel safe 
and reduce the likelihood of them misconstruing the situation.  
 
Insofar as possible, sticking to scheduled appointments and planning follow-up is 
particularly pertinent in this patient group. The trust which the neurologist may have 
worked hard to gain is likely to need continued authentication. For patients with 
BPD and PNES for example, it is advisable to continue seeing the patient at 
scheduled intervals (even if sparse) once the diagnosis has been made (33). This 
prevents the receipt of medical attention becoming conditional on escalating illness 
behaviours (33). Moreover, after the establishment of a therapeutic alliance, 
discharges should be planned and gradually phased insofar as possible. People 
with BPD are characteristically highly sensitive to perceived rejection which may 
trigger decompensation and frantic help-seeking elsewhere if this is not 
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thoughtfully managed (33). As such, careful planning will help both the patient and 
the health service as a whole.  
 
 
8. Maintaining hope 
 
The sense of shame, anxiety and hopelessness characteristically felt by people 
with BPD can engender a sense of hopelessness in the treating doctor, which may 
itself in turn be detected by these highly sensitive patients (33). The importance of 
reciprocal influence within the doctor-patient relationship has been demonstrated 
by the finding that either more positive or negative communication on one side 
elicits similar response styles from the other (49). Optimism and maintenance of 
hope on the part of the physician should therefore not be underestimated. 
 
Moreover, this optimism is not misplaced. Though previously believed to be a 
treatment-resistant condition, there is now a growing body of evidence showing 
that patients with BPD can be effectively helped (47). As such, we believe that 
working with and advocating for these patients is an extremely rewarding 
experience. 
 
 
Table 1. Treating people with BPD: some potentially difficult dynamics, 
underlying explanations and possible solutions 
 
Examples of perceived 
behaviour of people 
with BPD (50) 
Possible explanations 
for this behaviour 
Possible solutions for 
the doctor 
High healthcare 
utilisation 
 
High burden of psychiatric 
and physical comorbidities, 
coupled with health anxiety 
and fear of abandonment. 
Allowing enough time 
during the consultation to 
make the patient feel 
understood. 
Avoiding ‘bouncing’ 
patients between 
specialties where possible. 
Apparent intentional 
sabotage of care 
 
Part of self-destructive 
behaviour due to low self-
worth. 
Fear of abandonment by 
health professionals. 
Maintaining an open and 
validating approach. 
Organising follow-up. 
Difficulty establishing 
trust 
 
Histories of being 
repeatedly let down or 
taken advantage of in the 
past. 
Working towards a 
collaborative, transparent 
approach with careful 
explanations. 
Sticking to appointment 
  17 
times and agreements. 
Organising follow-up. 
Misunderstandings and 
angry reactions 
 
Negative interpretative bias 
to ambiguous faces in 
people with BPD. 
A genuinely compassionate 
approach from the 
physician will often instil 
greater patient confidence. 
‘Splitting’ in clinical 
teams 
Emotional dysregulation in 
patients can provoke strong 
reactions in clinicians which 
can become polarised. 
Recognising the pattern 
and using it informatively. 
Effective teamwork and 
adequate supervision. 
 
 
Key points 
 
1) Patients diagnosed with BPD are commonly encountered in a general 
hospital setting. 
2)1) BPD, a condition frequently encountered in the general hospital 
setting, is associated with significant physical and psychiatric comorbidity 
and excess mortality. 
3)2) BPD is a treatable condition associated with high rates of symptom 
remission. However, many patients experience persisting problems with 
personal and occupational relationships. 
4)3) Positive clinical outcomes hinge on the foundation of a therapeutic 
doctor-patient relationship, which presents a particular set of challenges . 
Inin the context of people with BPD., forging such an alliance presents a 
particular set of challenges. 
5)4) These challenges can often be overcome by adopting a collaborative, 
compassionate approach, with appropriate boundary-setting. This will 
require some investment by the doctor in their own emotional awareness, as 
well as effective teamwork and supervision. 
6)5) In parallel, maintaining a sense of hope and communicating 
conveying this to the patient can have powerful therapeutic effect.  
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